Suppr超能文献

小儿急性高氨血症:当前的诊断与管理策略

Acute pediatric hyperammonemia: current diagnosis and management strategies.

作者信息

Savy Nadia, Brossier David, Brunel-Guitton Catherine, Ducharme-Crevier Laurence, Du Pont-Thibodeau Geneviève, Jouvet Philippe

机构信息

Department of Pediatrics, CHU Sainte-Justine, University of Montreal, Montreal, QC, Canada,

Department of Pediatrics, Pediatric Intensive Care Unit, CHU Caen, Caen, France.

出版信息

Hepat Med. 2018 Sep 12;10:105-115. doi: 10.2147/HMER.S140711. eCollection 2018.

Abstract

Acute hyperammonemia may induce a neurologic impairment leading to an acute life-threatening condition. Coma duration, ammonia peak level, and hyperammonemia duration are the main risk factors of hyperammonemia-related neurologic deficits and death. In children, hyperammonemia is mainly caused by severe liver failure and inborn errors of metabolism. In an acute setting, obtaining reliable plasma ammonia levels can be challenging because of the preanalytical difficulties that need to be addressed carefully. The management of hyperammonemia includes 1) identification of precipitating factors and cerebral edema presence, 2) a decrease in ammonia production by reducing protein intake and reversing catabolism, and 3) ammonia removal with pharmacologic treatment and, in the most severe cases, with extracorporeal therapies. In case of severe coma, transcranial Doppler ultrasound could be the method of choice to noninvasively monitor cerebral blood flow and titrate therapies.

摘要

急性高氨血症可能导致神经功能损害,进而引发危及生命的急症。昏迷持续时间、血氨峰值水平和高氨血症持续时间是高氨血症相关神经功能缺损和死亡的主要危险因素。在儿童中,高氨血症主要由严重肝功能衰竭和先天性代谢缺陷引起。在急性情况下,由于需要仔细处理分析前的困难,获得可靠的血浆氨水平可能具有挑战性。高氨血症的治疗包括:1)识别诱发因素和是否存在脑水肿;2)通过减少蛋白质摄入和逆转分解代谢来减少氨的产生;3)采用药物治疗去除氨,在最严重的情况下,采用体外治疗。在严重昏迷的情况下,经颅多普勒超声可能是无创监测脑血流和调整治疗的首选方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7807/6140721/f9a7a970816b/hmer-10-105Fig1.jpg

相似文献

1
Acute pediatric hyperammonemia: current diagnosis and management strategies.
Hepat Med. 2018 Sep 12;10:105-115. doi: 10.2147/HMER.S140711. eCollection 2018.
2
Brain MRS glutamine as a biomarker to guide therapy of hyperammonemic coma.
Mol Genet Metab. 2017 May;121(1):9-15. doi: 10.1016/j.ymgme.2017.03.003. Epub 2017 Mar 10.
3
Survival after treatment with phenylacetate and benzoate for urea-cycle disorders.
N Engl J Med. 2007 May 31;356(22):2282-92. doi: 10.1056/NEJMoa066596.
4
The utility of EEG monitoring in neonates with hyperammonemia due to inborn errors of metabolism.
Mol Genet Metab. 2018 Nov;125(3):235-240. doi: 10.1016/j.ymgme.2018.08.011. Epub 2018 Aug 24.
6
Recent advances in the treatment of hyperammonemia.
Adv Drug Deliv Rev. 2015 Aug 1;90:55-68. doi: 10.1016/j.addr.2015.04.009. Epub 2015 Apr 17.
7
Hyperammonemia in the Pediatric Emergency Department.
Pediatr Emerg Care. 2024 Feb 1;40(2):156-161. doi: 10.1097/PEC.0000000000003121.
9
Late-onset ornithine transcarbamylase deficiency: treatment and outcome of hyperammonemic crisis.
Pediatrics. 2014 Apr;133(4):e1072-6. doi: 10.1542/peds.2013-1324. Epub 2014 Mar 10.
10
Hyperammonemia in urea cycle disorders: role of the nephrologist.
Am J Kidney Dis. 2001 May;37(5):1069-80. doi: 10.1016/s0272-6386(05)80026-5.

引用本文的文献

1
[Interpretation of the "Expert consensus on the diagnosis and treatment of neonatal hyperammonemia"].
Zhongguo Dang Dai Er Ke Za Zhi. 2025 May 15;27(5):515-523. doi: 10.7499/j.issn.1008-8830.2409151.
2
Perioperative care in pediatric OTC deficiency and goldenhar syndrome: a case report.
Front Pediatr. 2025 May 16;13:1501423. doi: 10.3389/fped.2025.1501423. eCollection 2025.
3
To Investigate the Laboratory Sample Criteria of Ammonia Measurement in Saudi Arabia.
Ann Afr Med. 2025 Jul 1;24(3):573-578. doi: 10.4103/aam.aam_80_24. Epub 2025 May 30.
4
Chemotactic Zn micromotor for treatment of high blood ammonia-associated hepatic encephalopathy.
Nat Commun. 2025 May 15;16(1):4525. doi: 10.1038/s41467-025-59650-0.
7
Emergency Management of Intoxication-Type Inherited Metabolic Disorders.
J Inherit Metab Dis. 2025 Mar;48(2):e70007. doi: 10.1002/jimd.70007.
10
Hyperosmolarity in children with hyperammonemia: a risk of brain herniation at the start of renal replacement therapy.
Front Pediatr. 2024 Jul 8;12:1431008. doi: 10.3389/fped.2024.1431008. eCollection 2024.

本文引用的文献

1
Osmotic Shifts, Cerebral Edema, and Neurologic Deterioration in Severe Hepatic Encephalopathy.
Crit Care Med. 2018 Feb;46(2):280-289. doi: 10.1097/CCM.0000000000002831.
2
Rifaximin ameliorates hepatic encephalopathy and endotoxemia without affecting the gut microbiome diversity.
World J Gastroenterol. 2017 Dec 21;23(47):8355-8366. doi: 10.3748/wjg.v23.i47.8355.
3
Is flumazenil an alternative for the treatment of hepatic encephalopathy?
Medwave. 2017 Dec 26;17(9):e7113. doi: 10.5867/medwave.2017.09.7113.
4
Brain MRS glutamine as a biomarker to guide therapy of hyperammonemic coma.
Mol Genet Metab. 2017 May;121(1):9-15. doi: 10.1016/j.ymgme.2017.03.003. Epub 2017 Mar 10.
5
Expanding the phenotype in argininosuccinic aciduria: need for new therapies.
J Inherit Metab Dis. 2017 May;40(3):357-368. doi: 10.1007/s10545-017-0022-x. Epub 2017 Mar 1.
6
Hepatic Encephalopathy.
N Engl J Med. 2016 Oct 27;375(17):1660-1670. doi: 10.1056/NEJMra1600561.
8
Pivotal role of glutamine synthetase in ammonia detoxification.
Hepatology. 2017 Jan;65(1):281-293. doi: 10.1002/hep.28852. Epub 2016 Nov 12.
10
Management of Hepatic Encephalopathy: A Primer.
Ann Pharmacother. 2016 Jul;50(7):569-77. doi: 10.1177/1060028016645826. Epub 2016 Apr 28.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验